Seres Therapeutics, Inc.

US$1.98As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:MCRBHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (37.38%)
Div yield —
ROE (144.35%)
Biotechnology
Beta (5Y) 0.56
PE TTM —
TSR TTM (87.70%)
Mkt cap US$19.89M
ROIC (44.47%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.05
3.55%
(92.76%)
Hold 3|4|11|12|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.05
0.05
0.05
0.05
22.08%
19.86%
20.41%
23.30%
Revenue$M
0.849
0.856
0.833
0.880
(2.07%)
(0.40%)
(3.84%)
0.95%
Peers (US$19.89M)
Cap (US$)
PE
20.68M
—
Capital
TTM
5Y
10Y
Leveragex
2.220
0.026
0.026
EBIT/Intx
0.647
0.258
0.227
Own earn%
(65.65)
(253.28)
(222.93)
Sh yield%
47.05
33.04
30.21
Owners
Insiders/Inst%
11.79
53.77
Short interest%
2.33
SBC / revenue%
2.26
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
3–9
$1 testx
—
Incr. ROIC%
18